
About Subhra Pharma Priavate Limited
Data last updated:
Subhra Pharma Priavate Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC206746. Its GSTIN is 27AAOCS6960J1ZM (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Manhar Hasmatrai Lilaramani and Rohini Manhar Lilaramani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Krupa Near Sainath Garden Opp Union Bank Of India Tata Colony Road Mulund(E), Mumbai, Maharashtra, India – 400081.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.98 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹23.1 Lakh (net margin 1.2%) and EBITDA of ₹79.85 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.
The company is associated with 1 brand: Subhra Pharma. As per MCA filings, the company has open charges of ₹9.33 Cr and satisfied charges of ₹2.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website subhrapharma.com.
Company details
Contact details
Subhra Pharma Priavate Limited's registered office is in Mumbai, Maharashtra. Its website is subhrapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressKrupa Near Sainath Garden Opp Union Bank Of India Tata Colony Road Mulund(E), Mumbai, Maharashtra, India – 400081
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Subhra Pharma Priavate Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Subhra Pharma Priavate operates one associated brand: Subhra Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Subhra Pharma exports pharmaceutical products including oncology and contrast media worldwide. | subhrapharma.com |
Business activity
The main business activity of Subhra Pharma Priavate is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Subhra Pharma Priavate Limited, buy the company report.
Financials of Subhra Pharma Priavate Limited
FY 2024 filings availableSubhra Pharma Priavate Limited reported revenue of ₹19.98 Cr (up 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 21% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹79.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Subhra Pharma Priavate Limited, buy the company report.
Board of directors of Subhra Pharma Priavate Limited
Subhra Pharma Priavate has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manhar Hasmatrai Lilaramani | Director | 19 Aug 2010 | 16 Years 3 Months | Current |
| Rohini Manhar Lilaramani | Director | 19 Aug 2010 | 16 Years 3 Months | Current |
Peer comparison
Subhra Pharma Priavate Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Drukst Biotech Private Limited | ₹20.04 Cr (FY 2023) | 16.0% | Lucknow, Uttar Pradesh, India | |||
| Medi Biotek (India) Private Limited | ₹20.02 Cr (FY 2023) | -56.0% | Chennai, Tamil Nadu, India | |||
| Chacha Medical Agencies Private Limited | ₹20.01 Cr (FY 2017) | 5.0% | Nashik, Maharashtra, India | |||
| Novelty Healthshine Private Limited | ₹20 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Subhra Pharma Priavate Limitedthis company | ₹19.98 Cr (FY 2024) | ₹23.1 Lakh | 1.2% | 21.0% | Mumbai, Maharashtra, India | |
| RR Pharmaceuticals Private Limited | ₹19.98 Cr (FY 2025) | -29.0% | New Delhi, Delhi, India | |||
| Arya Infraceuticals Private Limited | ₹19.95 Cr (FY 2024) | 8.0% | Mumbai, Maharashtra, India | |||
| Indace Chem India Private Limited | ₹19.93 Cr (FY 2024) | -29.0% | Thane, Maharashtra, India | |||
| Raddisun Pharmachem Industries Private Limited | ₹19.93 Cr (FY 2025) | -41.0% | Mumbai, Maharashtra, India | |||
| Raja Tradelinks Private Limited | ₹19.9 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Subhra Pharma Priavate Limited, buy the company report.
Auditor
Subhra Pharma Priavate Limited is audited by L K C & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L K C & CO | FY 2023 | 155652W |
Shareholding
The shareholding of Subhra Pharma Priavate Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Subhra Pharma Priavate Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Oct 2024 | 100992333 | Hdfc Bank Limited | ₹1.2 Cr | Open | |
| 28 Mar 2023 | 100706686 | Axis Bank Limited | ₹4.47 Cr | Open | |
| 18 Jul 2020 | 100357844 | Others | ₹44 Lakh | Open | |
| 21 May 2018 | 100182807 | Others | ₹22 Lakh | Open | |
| 07 Nov 2017 | 100135874 | Others | ₹3 Cr | Open |
To see the full charge records of Subhra Pharma Priavate Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Subhra Pharma Priavate Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Subhra Pharma Priavate Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Subhra Pharma Priavate has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCS6960J1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Subhra Pharma Priavate Limited, buy the company report.
Recent activity
Subhra Pharma Priavate Limited has 2 board changes on record since 2010: 2 appointments. The latest: Manhar Hasmatrai Lilaramani was appointed as Director on 19 Aug 2010.
6 earlier events are in the company report.
Frequently asked questions
Subhra Pharma Priavate is an active private limited company based in Mumbai, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 19 August 2010 (16+ years old) and is registered under CIN U24100MH2010PTC206746.
Subhra Pharma Priavate has 2 current directors:
- Manhar Hasmatrai Lilaramani - Director
- Rohini Manhar Lilaramani - Director
The latest financial statements of Subhra Pharma Priavate on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Subhra Pharma Priavate is 27AAOCS6960J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Subhra Pharma Priavate is U24100MH2010PTC206746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Subhra Pharma Priavate was incorporated on 19 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Subhra Pharma Priavate by revenue are Drukst Biotech Private Limited, Medi Biotek (India) Private Limited, Chacha Medical Agencies Private Limited, Novelty Healthshine Private Limited, RR Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manhar Hasmatrai Lilaramani was appointed as Director on 19 Aug 2010. Rohini Manhar Lilaramani was appointed as Director on 19 Aug 2010.
Subhra Pharma Priavate can be reached through the website subhrapharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Subhra Pharma Priavate is at Krupa Near Sainath Garden Opp Union Bank Of India Tata Colony Road MulundE, Mumbai, Maharashtra, India – 400081.
Subhra Pharma Priavate operates in the trading industry, in the wholesale segment.

